BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News

Cardiovascular Disorder (misc) News Articles

Get Our Industry eNewsletter FREE email:    
 Top Breaking News
GlaxoSmithKline To Invest $216 Million In New Factories, R&D     3/31/2014   More...
FDA Panel To Weigh Painkiller' Cardiac Risk     2/10/2014   More...
GlaxoSmithKline Heart Drug Misses Goal In Major Study     11/13/2013   More...
EU Agency Questions AstraZeneca PLC Over Heart Drug Trial     11/8/2013   More...
Merck & Co., Inc. Heart Drug Runs Into New Worry     10/24/2013   More...
Alnylam Pharmaceuticals's Gene Therapy Shows Strong Efficacy Data in Phase 1 Study     9/24/2013   More...
Bayer AG Grabs Approval for Adempas® as First Drug to Treat Rare Heart and Lung Disease     9/24/2013   More...
AstraZeneca PLC Looks for New Heart Drug Approval by Next May     9/18/2013   More...
Regado Biosciences, Inc. Kicks Off Big Clinical Trial for Heart Drug     9/17/2013   More...
Sequestration Saps 40% of Framingham Heart Study's Budget     9/10/2013   More...
Lancet Formally Retracts Jikei Heart Study of Novartis AG's Diovan     9/9/2013   More...
AstraZeneca PLC, Bristol-Myers Squibb Company: New Diabetes Drug Onglyza Doesn't Raise Heart Attack Risk     9/3/2013   More...
Novartis AG Admits 2 Ex-Employees Plus Prominent Japanese Doc Involved in Data Scandal     7/23/2013   More...
Resverlogix Corporation Plunges 93 Pct After Drug Fails Trial     7/1/2013   More...
Novartis Heart Drug Gets FDA's "Breakthrough" Status     6/26/2013   More...
 Featured Stories
Lower Salt Intake Likely To Have Had Key Role In Plummeting Cardiovascular Disease Deaths In Past Decade, British Medical Journal Reveals     4/15/2014   More...
Eating Beans, Peas, Lentils: Your Recipe For Lower Cholesterol? Canadian Medical Association Journal Reveals     4/8/2014   More...
More Research Links Poor Heart Health With Alzheimer's Risk, Wake Forest University Study     4/2/2014   More...
GlaxoSmithKline (GSK)'s New Smelly Drug Is An Utter Stinkbomb     4/1/2014   More...
A Cup Of Earl Grey "As Good As Statins" At Fighting Heart Disease, University of Calabria Study     4/1/2014   More...
Diet Drinks Linked To Heart Trouble In Women, University of Iowa Hospitals And Clinics Study     3/31/2014   More...
New Reason To Eat Oats For Heart Health, Tufts University Study     3/18/2014   More...
Vitamins Do Not Prevent Heart Disease, Cancer, U.S. Preventive Services Task Force Reveals     2/25/2014   More...
A Heart Expert's 10 Tips For Preventing Heart Disease     1/30/2014   More...
Sushi Could Boost Heart Disease Risk, Journal of Risk Research Reveals     12/2/2013   More...
Sofrito Contains Substances That Reduce The Risk Of Heart Disease, University of Barcelona Study     11/15/2013   More...
When Should You Take A Statin? The Answer Just Changed     11/14/2013   More...
Why Heart Attacks And Strokes Happen In The Morning, Brigham and Women's Hospital Study     11/13/2013   More...
Vitamins and Supplements May Not Protect You From Heart Diseases And Cancer, U.S. Preventive Services Task Force (USPSTF) Reveals     11/12/2013   More...
Vitamin C Could Ease COPD Effects, University of Utah Study     11/8/2013   More...
 More News
New England Research Institutes Release: TOPCAT Study Shows Spironolactone Did Not Reduce Serious Cardiovascular Events     4/11/2014   More...
ERT Introduces GE Healthcare’s QT Guard Plus™ Analysis System / T-Wave Morphology Analysis     4/10/2014   More...
Forest Laboratories, Inc. (FRX) And Almirall Provide Update On The Fixed Dose Combination Of Aclidinium And Formoterol In The U.S.     4/9/2014   More...
Aastrom Biosciences, Inc. (ASTM) Reports Data and Safety Monitoring Board Recommendation to Continue ixCELL-DCM Clinical Trial     4/9/2014   More...
Isis Pharmaceuticals, Inc. (ISIS) To Present At The 13th Annual Needham Healthcare Conference     4/1/2014   More...
Pfizer Inc. (PFE) Statement On FDA Approval Of Over-the-Counter Nexium® 24HR     3/31/2014   More...
AstraZeneca PLC (AZN) Announces Progress On Global PARTHENON Clinical Trial Program With BRILINTA (Ticagrelor) In High-Risk Cardiovascular Disease Patient Populations In Advance Of American College of Cardiology Scientific Session     3/17/2014   More...
Anavex Life Sciences Corp. (AVXL.OB): Research Report Reveals Cardioprotective Action Of Sigma-1 Receptor Agonists     3/4/2014   More...
Biocryst Pharmaceuticals (BCRX) Presents BCX4161 Phase 1 Trial And Kallikrein Inhibition Assay Results     3/3/2014   More...
Global Genomics Group (G3) And Quintiles, Inc. (Q) Collaborate On Cross-Functional Pan-Omic Study Of Biomarkers And Drug Target Discovery For Cardiovascular Diseases     2/19/2014   More...
Cempra's Solithromycin Demonstrates No QT Effects In Thorough QT Study     2/11/2014   More...
AstraZeneca PLC (AZN) To Collaborate With Shanghai Institutes for Biological Sciences On Cardiovascular Disease     1/29/2014   More...
Resverlogix Corporation (RVX.TO) Announces Combined RVX-208 Findings From SUSTAIN & ASSURE Phase 2b Trials     1/16/2014   More...
Dezima Pharma Completes Patient Enrolment for TULIP Phase 2B Study With CETP Inhibitor TA-8995     1/13/2014   More...
Dezima Pharma Completes Patient Enrollment For TULIP Phase 2B Study With CETP Inhibitor TA-8995     1/13/2014   More...

 

 

//-->